Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous BMT with Busulfan, Etoposide, and Filgrastim in AML/MDS
NCT00004899Phase 2Completed
- Sponsor
- Northwestern University
- Start
- Oct 1999
- Primary completion
- Aug 2004
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of filgrastim in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), sponsored by Northwestern University. Started Oct 1999; status: completed.
02
Drugs
filgrastim
03
Conditions
acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00004899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004899.